THYROID GLAND ANAPLASTIC CARCINOMA
Clinical trials for THYROID GLAND ANAPLASTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND ANAPLASTIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND ANAPLASTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive 'Tumor Seeker' drug tested in patients with advanced cancers
Disease control Recruiting nowThis is a very early study to test the safety of a new radioactive drug called [177Lu]Lu-AKIR001 in adults with advanced solid tumors that have a specific marker called CD44v6. The main goal is to find out what side effects occur and how much of the drug the body can handle. Rese…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
First trial launches to attack deadly thyroid cancer with drug and radiation double punch
Disease control Recruiting nowThis early-stage trial is testing a new combination treatment for a rare and very aggressive form of thyroid cancer. It combines two targeted drugs (dabrafenib and trametinib) with a precise form of radiation therapy. The main goal is to find the safest dose of this combination a…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC